Literature DB >> 29079577

Structural and functional effects of cytochrome b5 interactions with human cytochrome P450 enzymes.

Aaron G Bart1, Emily E Scott2,3.   

Abstract

The small heme-containing protein cytochrome b5 can facilitate, inhibit, or have no effect on cytochrome P450 catalysis, often in a P450-dependent and substrate-dependent manner that is not well understood. Herein, solution NMR was used to identify b5 residues interacting with different human drug-metabolizing P450 enzymes. NMR results revealed that P450 enzymes bound to either b5 α4-5 (CYP2A6 and CYP2E1) or this region and α2-3 (CYP2D6 and CYP3A4) and suggested variation in the affinity for b5 Mutations of key b5 residues suggest not only that different b5 surfaces are responsible for binding different P450 enzymes, but that these different complexes are relevant to the observed effects on P450 catalysis.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cytochrome; cytochrome P450; membrane protein; nuclear magnetic resonance (NMR); protein-protein interaction

Mesh:

Substances:

Year:  2017        PMID: 29079577      PMCID: PMC5743060          DOI: 10.1074/jbc.RA117.000220

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  High-level expression in Escherichia coli and purification of the membrane-bound form of cytochrome b(5).

Authors:  S B Mulrooney; L Waskell
Journal:  Protein Expr Purif       Date:  2000-06       Impact factor: 1.650

2.  Crystal structure of human cytochrome P450 2D6 with prinomastat bound.

Authors:  An Wang; Uzen Savas; Mei-Hui Hsu; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

3.  Human cytochrome b5 requires residues E48 and E49 to stimulate the 17,20-lyase activity of cytochrome P450c17.

Authors:  Jacqueline L Naffin-Olivos; Richard J Auchus
Journal:  Biochemistry       Date:  2006-01-24       Impact factor: 3.162

4.  Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase.

Authors:  A Bridges; L Gruenke; Y T Chang; I A Vakser; G Loew; L Waskell
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

5.  Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions.

Authors:  H Yamazaki; E M Gillam; M S Dong; W W Johnson; F P Guengerich; T Shimada
Journal:  Arch Biochem Biophys       Date:  1997-06-15       Impact factor: 4.013

6.  Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.

Authors:  Y Tan; C J Patten; T Smith; C S Yang
Journal:  Arch Biochem Biophys       Date:  1997-06-01       Impact factor: 4.013

7.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

Review 8.  The many roles of cytochrome b5.

Authors:  John B Schenkman; Ingela Jansson
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

9.  Cytochrome b5 increases the rate of product formation by cytochrome P450 2B4 and competes with cytochrome P450 reductase for a binding site on cytochrome P450 2B4.

Authors:  Haoming Zhang; Sang-Choul Im; Lucy Waskell
Journal:  J Biol Chem       Date:  2007-08-10       Impact factor: 5.157

10.  Human cytochrome P450 2A13 efficiently metabolizes chemicals in air pollutants: naphthalene, styrene, and toluene.

Authors:  Tatsuki Fukami; Miki Katoh; Hiroshi Yamazaki; Tsuyoshi Yokoi; Miki Nakajima
Journal:  Chem Res Toxicol       Date:  2008-02-12       Impact factor: 3.739

View more
  19 in total

1.  Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2.

Authors:  Charlie Fehl; Caleb D Vogt; Rahul Yadav; Kelin Li; Emily E Scott; Jeffrey Aubé
Journal:  J Med Chem       Date:  2018-05-24       Impact factor: 7.446

Review 2.  Monogenic Disorders of Adrenal Steroidogenesis.

Authors:  Elizabeth S Baranowski; Wiebke Arlt; Jan Idkowiak
Journal:  Horm Res Paediatr       Date:  2018-06-06       Impact factor: 2.852

3.  Crystal Structures of Drug-Metabolizing CYPs.

Authors:  D Fernando Estrada; Amit Kumar; Christopher S Campomizzi; Natalie Jay
Journal:  Methods Mol Biol       Date:  2021

4.  Specificity of the Redox Complex between Cytochrome P450 24A1 and Adrenodoxin Relies on Carbon-25 Hydroxylation of Vitamin-D Substrate.

Authors:  Amit Kumar; D Fernando Estrada
Journal:  Drug Metab Dispos       Date:  2019-07-09       Impact factor: 3.922

5.  Novel insights into oxidation of fatty acids and fatty alcohols by cytochrome P450 monooxygenase CYP4B1.

Authors:  Florian A Thesseling; Michael C Hutter; Constanze Wiek; John P Kowalski; Allan E Rettie; Marco Girhard
Journal:  Arch Biochem Biophys       Date:  2019-12-01       Impact factor: 4.013

6.  Use of Phenoxyaniline Analogues To Generate Biochemical Insights into the Interactio n of Polybrominated Diphenyl Ether with CYP2B Enzymes.

Authors:  Chao Chen; Jingbao Liu; James R Halpert; P Ross Wilderman
Journal:  Biochemistry       Date:  2017-12-19       Impact factor: 3.162

7.  Structure of Cytochrome P450 2C9*2 in Complex with Losartan: Insights into the Effect of Genetic Polymorphism.

Authors:  Sonia J Parikh; Chiara M Evans; Juliet O Obi; Qinghai Zhang; Keiko Maekawa; Karen C Glass; Manish B Shah
Journal:  Mol Pharmacol       Date:  2020-09-16       Impact factor: 4.436

8.  Structures of human cytochrome P450 1A1 with bergamottin and erlotinib reveal active-site modifications for binding of diverse ligands.

Authors:  Aaron G Bart; Emily E Scott
Journal:  J Biol Chem       Date:  2018-09-25       Impact factor: 5.157

9.  Comparison of Antifungal Azole Interactions with Adult Cytochrome P450 3A4 versus Neonatal Cytochrome P450 3A7.

Authors:  Malika P Godamudunage; Anne M Grech; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2018-07-10       Impact factor: 3.922

10.  Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents.

Authors:  Aaron G Bart; Goreti Morais; Venu R Vangala; Paul M Loadman; Klaus Pors; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2021-10-04       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.